New AI Tool Predicts Viral Variants Ahead of Time, Boosting Vaccine Design, US

Date:

A new AI tool developed by researchers at Harvard Medical School (HMS) and the University of Oxford called EVEscape has the ability to predict viral variants before they even emerge, greatly benefiting vaccine design. The tool consists of two elements: one that models evolutionary sequences to anticipate changes in the virus, and another that provides detailed biological and structural information.

In a study published in Nature, the team behind EVEscape revealed that if the tool had been in use at the beginning of the COVID-19 pandemic, it would have accurately predicted the most frequent mutations in the SAR-CoV-2 virus, as well as the emergence of concerning variants. Remarkably, the tool also demonstrated accurate predictions for other viruses, including HIV and influenza.

With the proven capabilities of EVEscape, the researchers are now using it to look ahead and predict SARS-CoV-2 variants of concern. They are releasing rankings of these variants every two weeks, offering valuable insights for vaccine and therapy design.

EVEscape is built upon a previous AI model called EVE (evolutionary model of variant effect), which was initially developed to predict the functionality of proteins based on evolutionary data across species. This earlier model helped identify genetic mutations associated with human diseases. During the COVID-19 pandemic, the researchers repurposed EVE to predict viral variants. By incorporating biological and structural details of the virus, including information about regions targeted by the immune system, they enhanced EVE’s capabilities for virus prediction.

To evaluate EVEscape’s effectiveness, the team used data from January 2020 to predict the future behavior of the SARS-CoV-2 virus. The results showed that EVEscape’s predictions of SARS-CoV-2 mutations during the pandemic were as accurate as experimental approaches that directly test the virus’s ability to bind to antibodies. Moreover, EVEscape outperformed experimental methods in predicting the most prevalent mutations. Importantly, the tool provided faster and more efficient predictions compared to lab-based testing, as it did not rely on waiting for antibodies to become available for testing. EVEscape also predicted the loss of effectiveness of certain antibody-based therapies as new variants emerged.

See also  Prolific secures $32M funding to train and stress-test AI models via its vast network of 120K individuals

The success of EVEscape does not confine itself solely to SARS-CoV-2. The researchers demonstrated its applicability as a predictive tool for HIV and influenza as well.

The code for EVEscape is openly available to researchers on GitHub, along with bi-weekly rankings of the most concerning SARS-CoV-2 variants on their website. The team also shares these rankings with public health entities, including the World Health Organization.

In conclusion, the development of EVEscape has ushered in a new era of predictive tools for viral variants. By accurately anticipating these variants, scientists can better design vaccines and therapies, ultimately combating the spread of infectious diseases more effectively. The availability of EVEscape’s code and rankings will enhance collaboration among researchers and aid public health organizations in staying ahead of viral mutations.

Frequently Asked Questions (FAQs) Related to the Above News

What is EVEscape?

EVEscape is a new AI tool developed by researchers at Harvard Medical School and the University of Oxford. It has the ability to predict viral variants before they emerge, which greatly benefits vaccine design.

How does EVEscape work?

EVEscape consists of two elements. One element models evolutionary sequences to anticipate changes in the virus, while the other provides detailed biological and structural information about the virus.

What is the significance of EVEscape's predictions?

The predictions made by EVEscape have proved to be accurate in the case of COVID-19 as well as other viruses like HIV and influenza. These predictions provide valuable insights for vaccine and therapy design.

How accurate are EVEscape's predictions?

According to a study published in Nature, EVEscape's predictions of SARS-CoV-2 mutations during the pandemic were as accurate as experimental approaches that directly test the virus's ability to bind to antibodies.

How does EVEscape compare to lab-based testing?

EVEscape provides faster and more efficient predictions compared to lab-based testing, as it does not require waiting for antibodies to become available for testing.

Can EVEscape predict the loss of effectiveness of therapies?

Yes, EVEscape can predict the loss of effectiveness of certain antibody-based therapies as new variants of the virus emerge.

What other viruses can EVEscape predict variants for?

EVEscape has demonstrated its applicability as a predictive tool for HIV and influenza, in addition to SARS-CoV-2.

How can researchers access EVEscape?

The code for EVEscape is openly available to researchers on GitHub, along with bi-weekly rankings of the most concerning SARS-CoV-2 variants on the researchers' website.

Who else receives EVEscape's rankings of concerning variants?

The researchers also share these rankings with public health entities, including the World Health Organization.

How does EVEscape contribute to combating the spread of infectious diseases?

By accurately predicting viral variants, EVEscape enables scientists to better design vaccines and therapies, ultimately helping to combat the spread of infectious diseases more effectively.

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.